Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01822613
Title Study of Safety and Efficacy of the Combination of LJM716 and BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals

esophagus squamous cell carcinoma


Docetaxel + Irinotecan + Paclitaxel

Alpelisib + Elgemtumab

Age Groups: adult
Covered Countries USA | CAN

No variant requirements are available.